Matthew Vogt, M.D., Ph.D.

Dr. Vogt was born and raised in St. Louis, MO, where he also began his studies at Washington University, obtaining a B.A. in Biology, followed by combined Ph.D. in Immunology and M.D. degrees.  His thesis was produced in the laboratory of Michael S. Diamond, M.D., Ph.D., studying the mechanisms of West Nile virus antibody neutralization in vitro and protection from infection in vivo.  After graduating, he moved to Boston, MA in 2013 for an internship and residency in Pediatrics in the Boston Combined Residency Program of both Boston Children’s Hospital (Harvard Medical School) and Boston Medical Center (Boston University).  While interviewing for Pediatric Infectious Diseases fellowships, he identified James E. Crowe, Jr., M.D. as a potential mentor due to their shared interests in the human immune response to respiratory viruses.  After matching into the fellowship at Vanderbilt, Dr. Vogt received the Pediatric Infectious Diseases Society-St. Jude Children’s Research Hospital Fellowship in Basic Research, a competitive research grant awarded annually to a single incoming Fellow in Pediatric Infectious Disease in the U.S.  After moving to Nashville, TN in 2016 and completing his first, clinical year of fellowship at the Monroe Carrell Jr. Children’s Hospital at Vanderbilt, Dr. Vogt began work in the Crowe lab in 2017 where he aims to characterize the human antibody response to the bronchiolitis-inducing picornaviruses enterovirus and rhinovirus.